Elga, Brent Cyrl .
HRN: 25-54-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/25/2024
08/01/2024
PO
3ml
TID
Amoebiasis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes